The structure of the skeletal and nonskeletal muscle calcium channel by Hofmann, Franz et al.
40. Colloquium der Gesellschaft für Biologische Chemie 
6.-8. April 1989 in Mosbach/Baden 
Molecular Mechanisms 
of Hormone Action 
Edited by 
U. Gehring, E. Helmreich and G. Schultz 
With 77 Figures 
Springer-Verlag Berlin Heidelberg New York 
London Paris Tokyo Hong Kong 
Prof. Dr. U L R I C H GEHRING 
Institut für Biologische Chemie 
Universität Heidelberg 
Im Neuenheimer Feld 510 
6900 Heidelberg, F R G 
Prof. Dr. ERNST J . M . HELMREICH 
Institut für Physiologische Chemie 
Universität Würzburg 
Koellikerstr. 2 
8700 Würzburg, F R G 
Prof. Dr. GÜNTER SCHULTZ 
Institut für Pharmakologie 
Freie Universität Berlin 
Thielallee 67-73 
1000 Berlin 33, F R G 
ISBN 3-540-51607-7 Springer-Verlag Berlin Heidelberg New York 
ISBN 0-387-51607-7 Springer-Verlag New York Berlin Heidelberg 
Library of Congress Cataloging-in-Publication Data. 
Gesellschaft für Biologische Chemie. Colloqium (40th: 1989: Mosbach, Baden-Württemberg, 
Germany). Molecular mechanisms of hormone action / 40. Colloquium der Gesellschaft für 
Biologische Chemie, 06.-08. April 1989 in Mosbach/Baden; edited by U. Gehring, E. Helmreich, and 
G. Schultz, p. cm. 1. Molecular endocrinology-Congresses. 2. Hormones-Physiological efTect-
Congresses. 3. Hormone receptors-Congresses. I. Gehring, Ulrich. II. Helmreich, E .J .M. (Ernst 
J .M.) , 1982- . III. Schultz, G. (Günter), 1936- . IV. Title. [DNLM: 1. Hormones-pharmacology-
congresses. WK 102 G389m] QP187.3.M64G47 1989 615'.36-dc20 D N L M / D L C 89-21860 
This work is subject to Copyright. All rights are reserved, whether the whole or part of the material is 
concerned, specifically the rights of translation, reprinting, re-use of illustrations, recitation, 
broadcasting, reproduction on microfilms or in other ways, and storage in data banks. Duplication of 
this publication or parts thereof is only permitted under the provisions of the German Copyright Law 
of September 9, 1965, in its Version of June 24, 1985, and a Copyright fee must always be paid. 
Violations fall under the prosecution act of the German Copyright Law. 
© Springer-Verlag Berlin Heidelberg 1989 
Printed in Germany 
The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of 
a specific Statement, that such names are exempt from the relevant protective laws and regulations 
and therefore free for general use. 
Typesetting: Overseas Typographers, Inc., Makati, Philippines 
Printing and binding: Brühische Universitätsdruckerei, Giessen 
2131/3145-543210 
Contents 
Part 1 1 
Mode of Action of Steroid Hormones: A Historical Review 
P. Karlson 3 
Interaction of Steroid Hormone Receptors with D N A 
M. Beato, U. Brüggemeier, G. Chalepakis, B. Gross, B. Pina, 
M. Schauer, E.P. Slater, and M. Truss 12 
Clustered Arrangement and Interaction of Steroid Hormone 
Receptors with Other Transcription Factors 
R. Renkawitz, R. Schule, C. Kaltschmidt, C. Baniahmad, 
A. Baniahmad, J. Altschmied, Ch. Steiner, and M. Muller . . . . 21 
Chromatin Template Remodeling and Steroid Receptor 
Transactivation of MMTV 
G.L. Hager 29 
Hormone-Dependent Transcriptional Activation by Thyroid 
Hormone Receptors: Functional Homology with Steroid 
Hormone Receptors 
S.M. Hollenberg, C.C. Thompson and R.M. Evans 35 
Subunit Structure of the Glucocorticoid Receptor 
U. Gehring, M. Rexin, W. Busch, B. Segnitz, and G. Zink . . . 44 
Modulation of Glucocorticoid Hormone Action by Oncogenes 
and Peptide Hormones 
B. Groner, W. Höck, W. Doppler, and R. Ball 53 
Studies on the Regulation of Glycogen and Lipid Metabolism 
by Insulin and Growth Factors: The Involvement of Receptor 
Tyrosine Kinase Activation and Casein Kinase II 
T . A J . Haystead and E.G. Krebs 61 
Part 2 73 
Genes Coding for G Proteins in Mammalian and Yeast Cells 
Y. Kaziro 75 
The ras Oncogene Protein 
M.S. Marshall, M.D. Schaber, U.S. Vogel, W.S. Hill, A.S. Ng, 
E.M. Scolnick, R.A.F. Dixon, LS. Sigal, and J.B. Gibbs . . . . 85 
X Contents 
Molecular Mechanisms of G-Protein Activation 
K.H. Jacobs, P. Gierschik, G. Hilf, C. Reithmann, 
D. Sidiropoulos, and T. Wieland 92 
Interaction of Transducin with Retinal c G M P Phosphodiesterase 
Ph. Deterre and M. Chabre 100 
Phosphonositide Metabolism and Visual Signal Transduction 
Z. Seiinger and B. Minke 108 
Hormonal Regulation of Phospholipases 
J.H. Exton 116 
Part 3 125 
Regulation of Ion Channels 
H. Reuter 126 
The Structure of the Skeletal and Nonskeletal Muscle 
Calcium Channel 
F. Hofmann, P. Ruth, T. Schneider, J. Felbel, S. Regulla, 
M. Biel, W. Nastainczyk, and V. Flockerzi 132 Involvement of Pertussis Toxin-Sensitive G-Proteins in the Modulation of Voltage-Dependent Ca2 + Channels by 
Extracellular Signals 
W. Rosenthal, S. Offermanns, J. Hescheler, K. Spicher, 
K.-D. Hinsch, U. Rudolph, and G. Schultz 139 
Multiple Roles of G Proteins in Coupling of Receptors to 
Ionic Channels and Other Effectors 
L. Birnbaumer, A. Yatani, J. Codina, A. Van Dongen, R. Graf, 
R. Mattera, J. Sanford, and A.M. Brown 147 
The Guanylate Cyclase Family 
D.L. Garbers 178 
Mechanisms for Hormonal Regulation of the Different Isoforms 
of Guanylate Cyclase 
F. Murad 186 
Catecholamine Receptors: Structure, Function, and Regulation 
M . G . Caron, B.K. Kobilka, M. Bouvier, W.P. Hausdorff, 
J.L. Benovic, M. Lohse, S. Cotecchia, J.W. Regan, A. Fargin, 
J.R. Raymond, and R.J. Lefkowitz 195 
Subject Index 201 
Contributors 
You will find the addresses at the beginning of the respective contribution 
Altschmied, J 21 
Ball, R. 53 
Baniahmad, A. 21 
Baniahmad, C. 21 
Beato, M. 12 
Benovic, J.L. 195 
Biel, M. 132 
Birnbaumer, L. 147 
Bouvier, M. 195 
Brown, A.M. 147 
Brüggemeier, U. 12 
Busch, W. 44 
Caron, M.G. 195 
Chabre, M. 100 
Chalepakis, G. 12 
Codina, J. 147 
Cotecchia, S. 195 
Deterre, Ph. 100 
Dixon, R.A.F. 85 
Doppler, W. 53 
Evans, R.M. 35 
Exton, J.H. 116 
Fargin, A. 195 
Felbel, J. 132 
Flockerzi, V. 132 
Garbers, D.L. 178 
Gehring, U. 44 
Gibbs, J.B. 85 
Gierschik, P. 92 
Graf, R. 147 
Groner, B. 53 
Gross, B. 12 
Hager, G.L. 29 
Hausdorff, W.P. 195 
Haystead, T.A.J. 61 
Hescheler, J. 139 
Hilf, G. 92 
Hill, W.S. 85 
Hinsch, K.-D. 139 
Höck, W. 53 
Hofmann, F. 132 
Hollenberg, S.M. 35 
Jakobs, K.H. 92 
Kaltschmidt, C. 21 
Karlson, P. 3 
Kaziro, Y. 75 
Kobilka, B.K. 195 
Krebs, E.G. 61 
Lefkowitz, R.J. 195 
Lohse, M. 195 
Marshall, M.S. 85 
Mattera, R. 147 
Minke, B. 108 
Muller, M. 21 
Murad, F. 186 
Nastainczyk, W. 132 
Ng, A.S. 85 
Offermanns, S. 139 
Pina, B. 12 
Raymond, J.R. 195 
Regan, J.W. 195 
Regulla, S. 132 
Reithmann, C. 92 
Renkawitz, R. 21 
Reuter, H. 126 
Rexin, M. 44 
Rosenthal, W. 139 
Rudolph, U. 139 
Ruth, P. 132 
Sanford, J. 147 
Schaber, M.D. 85 
Schauer, M. 12 
Schneider, T. 132 
Schule, R. 21 
Schultz, G. 139 
Scolnick, E.M. 85 
XII Contributors 
Segnitz, B. 44 
Seiinger, Z. 108 
Sidiropoulos, D. 92 
Sigal, LS. 85 
Slater, E.P. 12 
Spicher, K. 139 
Steiner, Ch. 21 
Thompson, C.C. 35 
Truss, M. 12 
Van Dongen, A. 147 
Vogel, U.S. 85 
Wieland, T. 92 
Yatani, A. 147 
Zink, G. 44 
The Structure of the Skeletal and Nonskeletal Muscle 
Calcium Channel 
F . HOFMANN1 , P . RUTH 1 , T . SCHNEIDER1, J . FELBEL1, S. REGULLA1 , M . BIEL1, 
W. NASTAINCZYK1, and V. FLOCKERZI1 
1 Introduction 
A number of fundamental biological processes such as mobility, secretion, and 
neurotransmission are regulated by a change in the cytosolic calcium concentration. 
The cytosolic calcium concentration is raised from around 0.1 to 1 j uM either by a 
release from cellular Stores or by an influx from the extracellular space through 
voltage-dependent calcium Channels. These Channels are located in the plasma and 
transverse tubulär membranes of many cells and are classified into at least three types 
(Nowycky et al. 1985), the T- (riny or /ransient), N- («either T- n o r L-, or «euronal), and 
L- (/arge or /ong-/asting) Channels. The L-type Channels are the target of different 
organic drugs, the calcium Channel blockers, which are used therapeutically in a variety 
of cardiovascular diseases. L- and N-type Channels are not only regulated by the 
membrane potential or drugs but also by hormones through phosphorylation and/or 
G proteins. The electrophysiological properties of the L-type Channel have been 
studied in great detail in cardiac, neuronal, and smooth muscle cells. In contrast, its 
biochemical and molecular structure has been elucidated up to now only in skeletal 
muscle. 
2 Structure of the Skeletal Muscle Calcium Channel 
The transversal tubulär membranes of the skeletal muscle contain high affinity binding 
sites for dihydropyridines and phenylalkylamines (Galizzi et al. 1986). The high 
concentration of the transversal tubulär binding sites has facilitated their purification 
toapparenthomogeneity(Curtisand Catterall 1984; Flockerzi et al. 1986a; Takahashi 
etal. 1987; Leungetal. 1988). The purified Channel contains three proteins of 165 kDa 
(ax), 55 kDa (ß), and 32 kDa (y) which copurify in a constant 1:1:1 ratio (Sieber et al. 
1987). A further glycoprotein which contains two disulfide-linked peptides of 135 kDa 
(a2) and 28 kDa (8) is present in the purified preparation. The relationship of this 
protein to the other three subunits is unknown. 
The oligomeric structure of the Channel is unclear at present. Electron microscopy 
of the purified Channel proteins suggests that at least the a r , ß-, and y-subunits are part 
of a higher ordered structure (Leung et al. 1988). The a r subuni t contains the binding 
sites for calcium Channel blockers (Sieber et al. 1987; Striessnig et al. 1986a, 1987; 
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Takahashi et al. 1987), is readily phosphorylated by cAMP-kinase at Ser 687 
(Röhrkasten et al. 1988), and has the primary structure of a voltage-dependent ion 
Channel (Tanabe et al. 1987; Ellis et al. 1988). Antibodies specific for the a,-, ß-, and 
y-subunit modulate the calcium Channel of cultured cells and the reconstituted skeletal 
muscle Channel supporting an oligomeric structure of the Channel and a modulatory 
role for the ß- and y-subunit (Campbell et al. 1988; Morton et al. 1988; Vilven et al. 
1988). 
The primary sequence of the a r , a2-, and ß-subunit has been elucidated recently 
by cloning of the corresponding cDN As. The structure of the y-subunit is not known 
at present. The «,-subunit contains four transmembrane regions which are composed 
of six transmembrane a-helices (Tanabe et al. 1987). The same topology is found in 
other voltage-dependent ion Channels. The deduced amino acid sequence of the a2 
protein is compatible with that of a peripheral membrane protein, although it contains 
three transmembrane a-helices (Ellis et al. 1988). In agreement with its behavior as 
glycoprotein several consensus sequences for glycosylation are present in a large 
extracellular domain of the protein. The ß-subunit contains four hydrophilic, 27 to 42 
amino acid long a-helices, each of which contains a homologous Stretch of eight amino 
acids (Ruth et al. 1989). The deduced amino acid of this protein is compatible with that 
of a peripheral membrane protein. The deduced amino acid sequence contains several 
potential phosphorylation sites. One of these sites, Ser 182, is phosphorylated in vitro 
by cAMP-kinase. A second and third site may be phosphorylated by cGMP-kinase 
and protein kinase C which enzymes modify rapidly the ß-subunit in vitro 
(Nastainczyk et al. 1987; Jahn et al. 1988). 
3 Binding Characteristics of the Purified Channel 
Only the 165 kDa (a,) subunit binds the dihydropyridines, phenylalkylamines, and 
benzothiazepines with high affinity (Flockerzi et al. 1986a; Striessnig et al. 1986b; 
Sieber et al. 1987). The respective apparent binding constants of the purified receptor 
are two- to tenfold higher than those of the membrane-bound receptor. The decreased 
affinity is due mainly to the diffkulty in separating rapidly bound and free ligand when 
the solubilized receptor is used. The binding of dihydropyridines and phenylal-
kylamines is modulated by calcium. The high affinity binding of PN 200-110, a 
dihydropyridine, occurs only in the presence of micromolar to millimolar concen-
trations of calcium. The binding of PN 200-110 is regulated allosterically further by 
diltiazem and Verapamil. In contrast, binding of devapamil, a Verapamil analog, occurs 
in the absence of calcium if carried out at4°C. Micromolar concentrations of calcium 
inhibit the binding of devapamil at 4° C. However, if the binding reaction is carried out 
at 30°C, devapamil binds only in the presence of a micromolar concentration of 
calcium and binding is inhibited by millimolar calcium. Preliminary analysis suggests 
that 0.1 to 1.0 j t i M calcium decreases the dissociation rate of devapamil at 30°C. 
Preincubation of the receptor for less than 20 min at 30° C in the absence of calcium 
and devapamil prevents binding of devapamil at 4° C. Apparently, a low concentration 
of calcium is necessary to stabilize the receptor at 30° C in a conformation which allows 
high affinity binding of devapamil. This apparent temperature dependence is 
reminiscent of the in vivo Situation where the Charge transfer of skeletal muscle is 
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blocked by calcium Channel blockers only at low temperatures a n d / o r after partial 
depolarization of the plasma membrane (Berwe et a l . 1987; Lamb and Walsh 1987; 
Rios and Brum 1987). Inactivation of the L-type calcium Channels, which is induced 
by an increase in cytosolic c a l c i u m , increases the affinity of c a l c i u m C h a n n e l b l o c k e r s 
by several Orders of magni tude (Bean 1984). This suggests that the conformation of the 
purified receptor protein complex may fluctuate between two states which are anal-
ogous to an active and inactivated Channel. 
4 Reconstitution of a Calcium Channel 
The T-tubular localization of the calcium Channel blocker binding sites has prevented 
so far a clear identification of their function. These binding sites may function only as 
a Charge carrier which links membrane depolarization with the intracellular calcium 
release. Myotubes and Single cells contain calcium Channels which are similar to L-type 
Channels of cardiac myocytes. T-tubular membranes contain L-type Channels if the 
membrane is reconstituted into a phospholipid bilayer. The open probability of these 
Channels increases after the addition of the calcium Channel agonist Bay K 8644, 
cAMP-kinase and ATP, and the a-subunit of the GTP-binding protein of G s 
(Flockerzi et al. 1986b; Talvenheimo et al. 1987; Hymel et al. 1988; Ma and Coronado 
1988; Pelzer et al. 1988; Yatani et al. 1988). The Channels are blocked by organic and 
inorganic calcium Channel blockers. Similarly, the purified receptor complex recon-
stitutes to an L-type calcium Channel. The opening probability increases after the 
addition of the Channel agonist Bay K 8644, cAMP-kinase, and ATP-Mg. The Channel 
is blocked by organic and inorganic calcium Channel blockers and has a Single Channel 
conductance of 20 pSi (Flockerzi et al. 1986b; Pelzer et al. 1988). However. the 
reconstituted proteins support also Channels of lower conductance which are not 
regulated by phosphorylation (Pelzer et al. 1988). The channel-forming protein is the 
a r s u b u n i t since (1) reconstitution of an isolated a r s u b u n i t leads to the formation of 
an L-type calcium Channel (Pelzer et al. 1988); (2) injection of the c D N A for the 
a r s u b u n i t into dysgenic muscle cells, which lack the a,-subunit , restores E-C coupling 
and a dihydropyridine-sensitive slow calcium Channel in these cells (Tanabe et al. 
1988); (3) antisense R N A complementary to the c D N A of the skeletal muscle 
a , -subuni t c D N A prevents the expression of cardiac muscle L-type Channel in oocytes 
(Lotan et al. 1989). Thus , it is quite clear that the a r s u b u n i t is a calcium Channel. This 
Channel has slower opening and closing kinetics than the Channel from other tissues, 
suggesting that the skeletal muscle Channel differs from that of other tissues. 
5 Structure of Nonskeletal Muscle L-Type Calcium Channels 
The identity of the L-type calcium Channel in other tissues has not been elucidated 
completely. Photoaflinity labeling of purified protein fractions and membranes sug-
gests that the cardiac muscle receptor for calcium Channel blockers is slightly larger 
than that of skeletal muscle. Apparent molecular weights of 195 versus 165 kDa have 
been reported (Schneider and Hofmann 1988; Chang and Hosey 1988). A similar 
molecular weight has been observed for the brain receptor (Striessnig et al. 1988). 
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Northern blots carried out with an oligonucleotide probe derived from the cDNA of 
the skeletal muscle «,-subunit show cross-hybridization to an 8.2 kb m R N A in brain, 
heart, and smooth muscle and to a 6.3 kb m R N A in skeletal muscle, suggesting again 
that the skeletal muscle Channel differs from that of other excitable tissues. Monoclonal 
antibodies against the a , -subunit of the rabbit skeletal muscle Channel do not 
specifically label proteins of other tissues. These antibodies detect the a,-subunit in the 
skeletal muscle from human , rabbit, guinea pig, hamster, cow, pig, chick, and frog. In 
contrast, antibodies directed against the a2-proteins of the rabbit skeletal muscle 
receptor label an identical or similar protein in a wide variety of tissues, including 
skeletal muscle, heart, brain, and smooth muscle (Schmid et al. 1986; Norman et al. 
1987). Similarly, the c D N A of the a2-protein hybridizes with the m R N A of other 
tissues in Nor thern blots (Ellis et al. 1988). This Supports again the notion that an 
identical a2-protein is present in all tissues, whereas the a,-subunit differs quite 
considerably from that of skeletal muscle. So far, it is unclear whether the ß- and 
y-subunit are part of the calcium Channel of other tissues. Preliminary data suggest that 
m R N A and a protein similar to the ß-subunit of skeletal muscle may be present in 
brain. It is therefore possible that both subunits are present in other tissues. The 
proteins associated with the N-type Channel are distinct from these proteins. N-type 
Channels bind specifically co-conotoxin and have a reported molecular weight of above 
200 kDa (Abe and Saisu 1987; Barhanin et al. 1988; Marqueze et al. 1988). 
6 In Vivo Regulation and Conclusions 
Calcium Channels are regulated in vivo by three mechanisms: The membrane po-
tential, protein kinases, and G proteins. The latter two mechanisms are of interestsince 
they allow hormonal regulation of Channel opening and closing. Cyclic AMP-
dependent protein kinase increases the open probability of the cardiac and some 
neuronal L-type Channels in vivo (Trautwein et al. 1986; Gray and Johnston 1987). The 
protein phosphorylated in vivo is unknown but the work with the skeletal muscle 
Channel suggests that it may be the a, -subunit. The a-subunits of G0 , G -t, and G s appear 
to regulate the opening and closing probability of calcium Channels in neuronal, 
neurosecretory, and cardiac cells (Yatani et al. 1987; Rosenthal et al. 1988). The exact 
mechanism has not been determined in most cases. The opening probability of 
reconstituted cardiac and skeletal muscle calcium Channels increases after addition of 
the a-subuni t of G s . However,it is unclear whether the a,-subunit of G s directly affects 
a cardiac calcium Channel in vivo, since inhibition of cAMP-kinase blocks the 
ß-adrenergic Stimulation of the cardiac calcium current. However, recently it has been 
found that the ß-adrenergic receptor of isolated tracheal smooth muscle cells 
stimulates the calcium current (Felbel et al. 1989). This Stimulation was not mimicked 
by the catalytic subunit of cAMP-kinase but was mimicked by GTPyS. This finding 
suggests that in these smooth muscle cells the a-subunit of G s may couple directly to 
the calcium Channel. These results support therefore the hypothesis that L-type 
calcium Channels are regulated by multiple mechanisms in vivo. 
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